By the end of 2030, the medical hyperspectral imaging market sales is expected to have grown at a compound annual growth rate (CAGR) of 6.2% from US$ 181.8 million in 2022 to US$ 294.7 million.
Growing number of healthcare ailments continues to drive advancements in medical imaging landscape. As such, computational power, image analysis, and hyperspectral cameras are the technological innovations being implemented all across the healthcare industry.
Non-invasive diseases as well as surgeries are being precisely figured out by imaging sensors. Also, they do not emit any sort of radiation to harm the patient or operator. According to FMI’s analysis, these factors will provide impetus to the market during the assessment period.
Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-12369
List of Key Players Covered in Medical Hyperspectral Imaging market are:
- IMEC
- Norsk Elektro Optikk
- Galileo
- Gilden Photonics
- Resonon
- XIMEA
- Gooch & Housego
- Chemlmage
- Applied Spectral Imaging
- Cubert
- EVK DI Kerschhaggl
- Headwall Photonics
- FluxData
“Proven success in North America and Europe is prompting medical hyperspectral imaging market players to shift their priorities to the developing economies. This factor will help in growth of the market between 2020 and 2030” – FMI Analyst
Unlock exclusive insights with our expert analysts :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12369
Key Takeaways :
- Hyperspectral camera holds the largest market share owing to latest advancements with respect to sensor development
- High preference for accuracy to boost prospects of MHSI in healthcare
- US and Europe to collectively account for nearly 40% revenue share
- India’s growth as a medical tourism hub to create opportunities for market players
Although FMI’s report is bullish on the use of hyperspectral imaging in medical applications, initial investments and reluctance to experiment will lead to limited adoption, especially in the next couple of years.
FMI’s discussion with stakeholders across the value chain revealed that concerns related to data storage, and the subsequent associated cost has been a key restraint for end-users. Many providers are offering cloud-based storage options, and it is likely that over the course of the forecast period, adoption will gradually increase.
Hyperspectral imaging used in a range of sectors apart from healthcare. The key hyperspectral imaging players are continuously focusing on offering technologically-superior products, not just for the healthcare industry.
According to FMI, holistic advances in hyperspectral imaging will boost the confidence of healthcare industry and fuel adoption. However, manufacturers will need to maintain that elusive balance between quality offerings and competitive pricing.
Unlock Tailored Insights: Customize Your Report for Maximum Impact :
https://www.futuremarketinsights.com/customization-available/rep-gb-12369
Want more insights?
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global medical hyperspectral imaging market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.
The study provides compelling insights on medical hyperspectral imaging market on the basis of product type (healthcare hyperspectral cameras, accessories), application (medical diagnostics (ophthalmology, wound diagnostics, oncology, GI Diseases, others)), tissue and cell biology, drug discovery, others), technology (Visible Hyperspectral Imaging, Near-Infrared Hyperspectral Imaging, Ultraviolet Hyperspectral Imaging, Short-Wave Infrared Imaging, and Mid-Wave Infrared Hyperspectral Imaging), end-user (diagnostic centres, hospitals, research & academic centres, pharmaceutical & biotechnology companies) across seven regions.
Key Regions Covered:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
